Skip to main content

Peer Review reports

From: Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial

Original Submission
12 Apr 2019 Submitted Original manuscript
23 Jul 2019 Reviewed Reviewer Report - Juan Yepes
15 Sep 2019 Reviewed Reviewer Report - Pamela Shaw
12 Oct 2019 Author responded Author comments - Atsushi Fukunaga
Resubmission - Version 2
12 Oct 2019 Submitted Manuscript version 2
4 Nov 2019 Editorially accepted
6 Jan 2020 Article published 10.1186/s13063-019-3878-2

You can find further information about peer review here.

Back to article page